Filtrer vos résultats
- 3
- 1
- 4
- 4
- 2
- 1
- 1
- 4
- 3
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 4
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
triés par
|
PRESCRIPTION OF DIRECT ORAL ANTICOAGULANTS TO PATIENTS WITH MODERATE TO ADVANCED CKD : TOO LITTLE OR JUST RIGHT?Nephrology Dialysis Transplantation, 2021, 36 (1), pp.307
Article dans une revue
hal-03578404v1
|
|||
|
Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle?Nephrology Dialysis Transplantation, 2021, ⟨10.1093/ndt/gfab223⟩
Article dans une revue
hal-03451534v1
|
||
|
Once-Monthly Continuous Erythropoietin Receptor Activator (CERA) in Patients with Hemodialysis-Dependent Chronic Kidney Disease: Pooled Data from Phase III TrialsAdvances in Therapy, 2016, 33 (4), pp.610-625. ⟨10.1007/s12325-016-0309-6⟩
Article dans une revue
hal-03574434v1
|
||
|
The fate of triaged and rejected manuscriptsNephrology Dialysis Transplantation, 2015, 30 (12), pp.1947 - 1950. ⟨10.1093/ndt/gfv387⟩
Article dans une revue
hal-01907593v1
|